TA-1

TA-1 is presented here as a laboratory catalogue entry for research environments that need clear identification, labelled variants, and direct access to supporting records. The current listing includes 1 labelled variant: 10mg. That structure keeps the page useful as both a procurement reference and an indexable resource covering stock visibility, pricing context, and documentation.

Within the wider Au Peptide Labs catalogue, TA-1 sits alongside Melanotan 1, IGF-1 LR3, and Retatrutide. Researchers often review neighbouring compounds before selecting a comparator or deciding which sequence belongs in a screening panel. Keeping those internal paths close to the product page improves traceability and helps laboratory buyers compare materials without relying on vague or consumer-style copy.

In research literature, TA-1 is generally treated as thymosin alpha-1 (Tα1), a 28-amino acid N-terminally acetylated thymic peptide that acts as an endogenous TLR2 and TLR9 agonist. Tα1 is naturally secreted by thymic epithelial cells and has been characterised as an agonist at Toll-like receptors 2 and 9 (TLR2, TLR9) in dendritic cell and macrophage assay models, activating downstream MyD88-NF-κB and MAPK signalling pathways. In T-lymphocyte assays it is studied for enhancement of CD4+ T-helper cell differentiation and NK cell cytotoxic activity. Unlike many immunomodulatory peptides, Tα1 is defined by an N-terminal acetyl group on its Ser1 residue — loss of this modification substantially reduces biological activity in receptor-based assays, making N-terminal integrity a critical quality attribute to verify before functional experiments.

Research panels using Tα1 commonly examine innate-to-adaptive immune signalling transitions, dendritic cell maturation markers (MHC-II, CD80/86 upregulation), and cytokine secretion profiles (IFN-α, IL-12) in primary PBMC or monocyte-derived dendritic cell models. It is also used as a positive control in TLR agonism reporter assays. For laboratory teams, the practical emphasis is usually on sequence identity, receptor or pathway relevance where documented, and whether TA-1 behaves consistently across stability, purity, and analytical verification workflows. Variant labels on this page support clearer internal referencing when multiple labelled variants are under review.

If a product-specific file is not attached to this listing, the wider COA library remains the correct reference point for current published documentation. The COA section is useful for confirming how the product is labelled in the catalogue, whether purity information has been published, and whether the laboratory record for the material is complete before bench use.

When teams compare TA-1 with Melanotan 1, IGF-1 LR3, and Retatrutide, COA access also helps keep comparator decisions grounded in documented material identity rather than assumption. That is especially important for research pages that combine pricing, variant selection, and analytical records on a single URL.